Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy

Completed · Not applicable

Conditions studied: Schizophreniform Disorders

In brief

To test the feasibility of a clinical trial implementing I-CAT, a novel therapeutic intervention combining strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. autonomic, endocrine, immune indices of stress reactivity, symptom severity) and distal measures (function, relapse, quality of life) for 40 people with first episode psychosis in the context of a small randomized controlled trial.

Key facts

Study ID
NCT03067311
Run by
University of North Carolina, Chapel Hill
People needed
38
Starts
2016-10-03
Expected to finish
2020-03-30
Last updated by the study team
2021-03-03

Who can join

Age: 15 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.